HIV enters the brain and doesn't leave, drugs intended to reduce brain inflammation increase virus levels
HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave.
Jun 8, 2026
0
4
Amino Acids, Peptides, and Proteins: News and Research on Globulins
MeSH tree: D12.776.377
Engineered stem cells reverse new-onset type 1 diabetes in mice
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. ...
Jun 7, 2026
0
24
New drug cuts relapse risk by half in rare immune disorder trial
Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of relapse in patients with IgG4-related disease, a rare chronic immune condition often misdiagnosed as ...
Jun 4, 2026
0
11
Immune barrier may explain why mRNA shots struggle to block nasal infection
A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and throat from respiratory viruses has been identified. The discovery, led by researchers from the University ...
Jun 4, 2026
0
6
Novel vaccine adjuvant could make it easier to eradicate polio
In the United States, children routinely receive an injectable form of the polio vaccine. This vaccine is very effective at preventing illness, but it doesn't block transmission of the polio virus as well as the oral polio ...
Jun 3, 2026
0
6
Serious infection risks linked to targeted cancer therapies
A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies. ...
Jun 2, 2026
0
6
Teclistamab extends remission in relapsed myeloma, with 70% progression-free at 18 months
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained in remission far longer than those receiving standard therapies, according to results from a major ...
May 29, 2026
0
10
Scientists validate a link between autoimmunity and long COVID
A Mount Sinai-led research team has demonstrated that autoimmunity, in which the body's immune system attacks its own tissues, is responsible for the often-debilitating and confounding symptoms of long COVID in a subset of ...
May 28, 2026
0
31
FDA approves Enhertu as neoadjuvant, adjuvant treatment for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the neoadjuvant and adjuvant treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive ...
May 25, 2026
0
10
Clinical trial tests virus-immunotherapy combination for neuroendocrine tumors
A Phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment. Researchers at Sylvester Comprehensive ...
May 21, 2026
0
4
